HBO-PC Reprograms Neuroimmune Metabolism Through Disruption of the LRG1-HIF-1α-IL-6-STAT3 Amplification Loop Attenuates Pyroptosis and Ischemia-Reperfusion Injury.
{"title":"HBO-PC Reprograms Neuroimmune Metabolism Through Disruption of the LRG1-HIF-1α-IL-6-STAT3 Amplification Loop Attenuates Pyroptosis and Ischemia-Reperfusion Injury.","authors":"Wenying Lv, Junzhe Lv, Kexin Xiong, Shunshun Yuan, Jingyao Yang, Dazhi Guo","doi":"10.1002/cns.70907","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Neuroinflammation and pyroptosis driven by excessive microglial activation play key roles in cerebral ischemia-reperfusion injury (CIRI). Hyperbaric oxygen preconditioning (HBO-PC) exhibits neuroprotective effects, but its mechanisms remain unclear. Leucine-rich α-2-glycoprotein 1 (LRG1) is implicated in CIRI pathology, yet whether HBO-PC modulates neuroinflammation and pyroptosis via LRG1 is unknown.</p><p><strong>Methods: </strong>A mouse CIRI model was generated by middle cerebral artery occlusion. HBO-PC and LRG1 siRNA knockdown were applied. Neurological function and molecular changes were evaluated.</p><p><strong>Results: </strong>HBO-PC reduced infarct volume and improved neurological outcomes, while downregulating LRG1 in neurons and microglia. LRG1 promoted HIF-1α accumulation by inhibiting prolyl hydroxylase activity, leading to caspase-3-dependent GSDME cleavage and pyroptosis. Released IL-6 activated STAT3, which further transcriptionally upregulated LRG1, forming a self-amplifying HIF-1α/GSDME/IL-6/STAT3 loop. HBO-PC disrupted this circuit and shifted microglia toward an anti-inflammatory phenotype.</p><p><strong>Conclusion: </strong>HBO-PC protects against CIRI by breaking the LRG1-HIF-1α-IL-6-STAT3 feedback loop, thereby attenuating pyroptosis and neuroinflammation while promoting anti-inflammatory microglial polarization. LRG1 represents a promising therapeutic target in ischemic brain injury.</p>","PeriodicalId":154,"journal":{"name":"CNS Neuroscience & Therapeutics","volume":"32 5","pages":"e70907"},"PeriodicalIF":5.0000,"publicationDate":"2026-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13127231/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"CNS Neuroscience & Therapeutics","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1002/cns.70907","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"NEUROSCIENCES","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Neuroinflammation and pyroptosis driven by excessive microglial activation play key roles in cerebral ischemia-reperfusion injury (CIRI). Hyperbaric oxygen preconditioning (HBO-PC) exhibits neuroprotective effects, but its mechanisms remain unclear. Leucine-rich α-2-glycoprotein 1 (LRG1) is implicated in CIRI pathology, yet whether HBO-PC modulates neuroinflammation and pyroptosis via LRG1 is unknown.
Methods: A mouse CIRI model was generated by middle cerebral artery occlusion. HBO-PC and LRG1 siRNA knockdown were applied. Neurological function and molecular changes were evaluated.
Results: HBO-PC reduced infarct volume and improved neurological outcomes, while downregulating LRG1 in neurons and microglia. LRG1 promoted HIF-1α accumulation by inhibiting prolyl hydroxylase activity, leading to caspase-3-dependent GSDME cleavage and pyroptosis. Released IL-6 activated STAT3, which further transcriptionally upregulated LRG1, forming a self-amplifying HIF-1α/GSDME/IL-6/STAT3 loop. HBO-PC disrupted this circuit and shifted microglia toward an anti-inflammatory phenotype.
Conclusion: HBO-PC protects against CIRI by breaking the LRG1-HIF-1α-IL-6-STAT3 feedback loop, thereby attenuating pyroptosis and neuroinflammation while promoting anti-inflammatory microglial polarization. LRG1 represents a promising therapeutic target in ischemic brain injury.
期刊介绍:
CNS Neuroscience & Therapeutics provides a medium for rapid publication of original clinical, experimental, and translational research papers, timely reviews and reports of novel findings of therapeutic relevance to the central nervous system, as well as papers related to clinical pharmacology, drug development and novel methodologies for drug evaluation. The journal focuses on neurological and psychiatric diseases such as stroke, Parkinson’s disease, Alzheimer’s disease, depression, schizophrenia, epilepsy, and drug abuse.